WHO ICTRP trial

To assess the efficacy of methotrexate in extending the life of arterio-venous…

CTRI/2021/08/035382 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/08/035382
Public title To assess the efficacy of methotrexate in extending the life of arterio-venous fistulas and artificial grafts in patients undergoing dialysis
Scientific title To Assess The Efficacy of Ultrasound Guided Peri-stenotic Injectable Methotrexate In Preventing The Re-stenosis Of The Upper Limb Arterio Venous Fistula or Arterio Venous Grafts in chronic kidney disease patients
Primary sponsor Dr Ajay Kumar Dabas
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: O- Medical and Surgical
Interventions Intervention1: Methotrexate injection: After angioplasty / surgery for stenosis in Arterio venous fistula or artrerio venous graft patients will be injected (USG guided) with methotrexate peri- adventitially (sub-cutaneous ) at the site of…
Registration date Apr 8, 2021
Target size 15
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations